Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers

SIMPLE SUMMARY: The current standard-of-care (SOC) genetic testing of myeloid cancers in limited by resolution and/or is targeted to investigate limited regions/genes in the genome. As a result, these genomes remain poorly characterized and warrant further investigation using emerging technologies....

Descripción completa

Detalles Bibliográficos
Autores principales: Sahajpal, Nikhil Shri, Mondal, Ashis K., Singh, Harmanpreet, Vashisht, Ashutosh, Ananth, Sudha, Saul, Daniel, Hastie, Alex R., Hilton, Benjamin, DuPont, Barbara R., Savage, Natasha M., Kota, Vamsi, Chaubey, Alka, Cortes, Jorge E., Kolhe, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296552/
https://www.ncbi.nlm.nih.gov/pubmed/37370824
http://dx.doi.org/10.3390/cancers15123214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296552/
https://www.ncbi.nlm.nih.gov/pubmed/37370824
http://dx.doi.org/10.3390/cancers15123214

Ejemplares similares